Therapeutic Options and Cost-Effectiveness for Rheumatoid Arthritis Treatment

被引:0
|
作者
Alexandros A. Drosos
Eleftherios Pelechas
Evripidis Kaltsonoudis
Paraskevi V. Voulgari
机构
[1] University of Ioannina,Rheumatology Clinic, Department of Internal Medicine, Medical School
来源
关键词
csDMARDs; bDMARDs; Triple therapy; Cost-effectiveness; Work productivity; Quality of life;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [41] Cost-effectiveness of biologic treatment for rheumatoid arthritis in clinical practice: An achievable target?
    Modena, Vittorio
    Bianchi, Gerolamo
    Roccatello, Dario
    AUTOIMMUNITY REVIEWS, 2013, 12 (08) : 835 - 838
  • [42] COST-EFFECTIVENESS OF RITUXIMAB VS ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS
    Bynum, L. A.
    Joshi, N.
    VALUE IN HEALTH, 2010, 13 (03) : A126 - A126
  • [43] Cost-effectiveness of treatment strategies for rheumatoid arthritis patients with inadequate response to methotrexate
    Patel, VD
    Hay, J
    VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
  • [44] COST-EFFECTIVENESS OF EARLY TREATMENT OF ACPA POSITIVE RHEUMATOID ARTHRITIS PATIENTS WITH ABATACEPT
    Neubauer, A. S.
    Minartz, C.
    Herrmann, K. H.
    Postema, R.
    Baerwald, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 442 - 443
  • [45] Cost-effectiveness of Tofacitinib in the Treatment of Moderate to Severe Rheumatoid Arthritis in South Korea
    Lee, Min-Young
    Park, Sun-Kyeong
    Park, Sun-Young
    Byun, Ji-Hye
    Lee, Sang-Min
    Ko, Su-Kyoung
    Lee, Eui-Kyung
    CLINICAL THERAPEUTICS, 2015, 37 (08) : 1662 - 1676
  • [46] Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia
    Carolina Valle-Mercado
    Maria-Fernanda Cubides
    Monica Parra-Torrado
    Diego Rosselli
    Rheumatology International, 2013, 33 : 2993 - 2997
  • [47] COST-EFFECTIVENESS ANALYSIS OF SUBCUTANEOUS TOCILIZUMAB PLUS METHOTREXATE IN RHEUMATOID ARTHRITIS TREATMENT
    Oksuz, E.
    Malhan, S.
    Yanik, L.
    Koc, E.
    Erdogan-Ciftci, E.
    Celik, H.
    Orfanos, P.
    VALUE IN HEALTH, 2018, 21 : S295 - S295
  • [48] COST-EFFECTIVENESS OF BIOLOGIC AGENTS COMPARED WITH METHOTREXATE IN THE TREATMENT OF RHEUMATOID ARTHRITIS IN COLOMBIA
    Valle-Mercado, C.
    Cubides, M. F.
    Parra-Torrado, M.
    Rosselli, D.
    VALUE IN HEALTH, 2011, 14 (07) : A311 - A311
  • [49] Cost-effectiveness of biological therapy compared with methotrexate in the treatment for rheumatoid arthritis in Colombia
    Valle-Mercado, Carolina
    Cubides, Maria-Fernanda
    Parra-Torrado, Monica
    Rosselli, Diego
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 2993 - 2997
  • [50] Cost-effectiveness of adalimumab (Humira™) in the treatment of US patients with rheumatoid arthritis (RA)
    Bansback, N
    Brennan, A
    Sengupta, N
    VALUE IN HEALTH, 2004, 7 (03) : 241 - 241